-
How COVID-19 Changed Cancer Care
A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.
by Eric Fitzsimmons
-
2021: The Year in Cancer News
The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.
by Cancer Today Staff
-
Forward Look
A Closer Look at Survivorship Among HispanicsStudy investigates factors that contribute to cancer outcomes in a large and growing segment of the U.S. population.
by Sharon Tregaskis
-
Forward Look
There’s Time to Consider Fertility Preservation OptionsWomen with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.
by Kris Conner
-
Healthy Habits
Mushroom for ImprovementA broad review of existing research finds eating more mushrooms is associated with lower risk of developing cancer.
by Ashley P. Taylor
-
From the Editor-in-Chief
Astronomy Meets PathologyData analysis platforms that map the cosmos are being applied to map the tumor microenvironment, an approach that could revolutionize cancer pathology.
by William G. Nelson, MD, PhD
-
Forward Look
CAR T Cells for Blood Cancer PatientsResearchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
-
Quality Questions
When you are diagnosed with cancer, how can you be sure you're getting appropriate care?
by K.J. Bannan
-
Improving Your Diet One Plate at a Time
The New American Plate suggests gradual changes to build healthier eating habits.
by Jon Kelvey
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff